IDD Daily Brief: Monday, Nov 16, 2026 — Palantir's CTO sells $64.93 million, Founders Fund reports a smaller SpaceX stake and Incyte drops a Phase 3 study
Published
> “Knowing how to struggle well and enjoy it is what it’s all about.” — Ray Dalio
The Big Picture
- Palantir's CTO sold $64.93 million of stock. Chief Technology Officer Shyam Sankar converted 384,680 Class B shares to Class A and sold them on Nov. 10 and 11 under a Rule 10b5-1 plan adopted Aug. 10, according to a Form 4.
- Founders Fund entities reported a smaller SpaceX stake. Partnerships and related entities controlled by Peter Thiel reported 314,357,058 SpaceX Class A shares, or 3.8% of the class, as of Sept. 30, down from 427,306,025 shares, or 5.5%, as of June 30, according to a Schedule 13G/A.
- Incyte dropped a planned Phase 3 ovarian cancer study. The company will not proceed with MAESTRA-3, a study of its CDK2 inhibitor INCB123667 with bevacizumab, citing portfolio prioritization rather than safety or efficacy findings, it said in an 8-K.
Company News
- Incyte (INCY) said MAESTRA-3 had been expected to begin in the fourth quarter of 2026 as a first-line maintenance study in ovarian cancer, and that it does not expect the decision to affect its financial guidance or long-term outlook, according to an 8-K filed Nov. 13.
- Xylem (XYL): The board approved a new program on Nov. 13 authorizing the company to buy back up to $1.5 billion of its common stock. The program has no expiration date, does not obligate Xylem to buy any particular amount and may be suspended at any time, according to an 8-K.
- Moderna (MRNA): Chief Legal Officer Shannon Thyme Klinger will retire on March 31, 2027, under a transitional services and retirement agreement. She will receive $1,628,300 in severance and may receive $2,500,000 tied to the Arbutus and Genevant litigation and up to $5,500,000 tied to the litigation with Pfizer and BioNTech, the company said in an 8-K.
Insider & Institutional Watch
- Palantir Technologies (PLTR): Sankar sold 300,000 shares on Nov. 10 for $50,108,263 and 84,680 shares on Nov. 11 for $14,824,936. He directly held 857,616 Class A and 3,243,918 Class B shares afterward, according to a Form 4.
- Frontdoor (FTDR): CEO William Cobb exercised options on 208,747 shares at $26.42 and sold 208,747 shares from Nov. 10 to Nov. 12 for $20,387,276 under a Rule 10b5-1 plan adopted Aug. 10, according to a Form 4.
- Live Nation Entertainment (LYV): President and CFO Joe Berchtold exercised 93,537 stock options granted in 2017 at $29.03 on Nov. 13 and sold 93,537 shares that day for $16,728,556. He held 901,617 shares afterward, according to a Form 4.